WallStreetZenWallStreetZen

NASDAQ: BLUE
Bluebird Bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for BLUE

Based on 6 analysts offering 12 month price targets for Bluebird Bio Inc.
Min Forecast
$4.21+286.24%
Avg Forecast
$6.87+530.09%
Max Forecast
$13.00+1,092.66%

Should I buy or sell BLUE stock?

Based on 6 analysts offering ratings for Bluebird Bio Inc.
Buy
Strong Buy
2 analysts 33.33%
Buy
2 analysts 33.33%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BLUE stock forecasts and price targets.

BLUE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-21Find Out Why
lockedlocked$00.00+00.00%2023-12-15Find Out Why
lockedlocked$00.00+00.00%2023-12-12Find Out Why
lockedlocked$00.00+00.00%2023-12-08Find Out Why
lockedlocked$00.00+00.00%2023-11-08
HSBC
Bottom 18%
18
Strong BuyInitiates Coverage On$4.21+286.24%2023-09-06

1 of 1

Forecast return on equity

Is BLUE forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
24.42%

Forecast return on assets

Is BLUE forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BLUE revenue forecast

What is BLUE's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$111.7M+413.92%
Avg 2 year Forecast
$175.5M+707.87%
Avg 3 year Forecast
$98.4M+352.96%
BLUE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BLUE revenue growth forecast

How is BLUE forecast to perform vs Biotechnology companies and vs the US market?
Company
95.95%
Industry
48.24%
Market
9.9%
BLUE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BLUE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BLUE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BLUE$1.09$6.87+530.09%Buy
CAPR$3.86$24.00+521.76%Strong Buy
ANIX$3.77$12.00+218.30%Buy
CRBP$27.15$51.00+87.85%Buy
ELEV$2.77$5.50+98.56%Buy

Bluebird Bio Stock Forecast FAQ

Is Bluebird Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: BLUE) stock is to Buy BLUE stock.

Out of 6 analysts, 2 (33.33%) are recommending BLUE as a Strong Buy, 2 (33.33%) are recommending BLUE as a Buy, 2 (33.33%) are recommending BLUE as a Hold, 0 (0%) are recommending BLUE as a Sell, and 0 (0%) are recommending BLUE as a Strong Sell.

If you're new to stock investing, here's how to buy Bluebird Bio stock.

What is BLUE's revenue growth forecast for 2024-2026?

(NASDAQ: BLUE) Bluebird Bio's forecast annual revenue growth rate of 95.95% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 48.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.9%.

Bluebird Bio's revenue in 2024 is $21,726,000.On average, 6 Wall Street analysts forecast BLUE's revenue for 2024 to be $12,207,825,303, with the lowest BLUE revenue forecast at $6,199,363,164, and the highest BLUE revenue forecast at $15,952,153,185. On average, 4 Wall Street analysts forecast BLUE's revenue for 2025 to be $19,190,473,082, with the lowest BLUE revenue forecast at $7,990,290,300, and the highest BLUE revenue forecast at $26,108,612,497.

In 2026, BLUE is forecast to generate $10,759,776,525 in revenue, with the lowest revenue forecast at $10,759,776,525 and the highest revenue forecast at $10,759,776,525.

What is BLUE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BLUE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BLUE's Price Target?

According to 6 Wall Street analysts that have issued a 1 year BLUE price target, the average BLUE price target is $6.87, with the highest BLUE stock price forecast at $13.00 and the lowest BLUE stock price forecast at $4.21.

On average, Wall Street analysts predict that Bluebird Bio's share price could reach $6.87 by Dec 21, 2024. The average Bluebird Bio stock price prediction forecasts a potential upside of 530.09% from the current BLUE share price of $1.09.

What is BLUE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BLUE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.